Volatile Week, but Green? Click to watch the new Podcast.

CytomX Therapeutics Stock Forecast

NASDAQ:CTMX BUY SELL

$1.94 (5.43%)

Volume: 1.06M

Closed: Jul 05, 2022

Hollow Logo Score: 3.577

CytomX Therapeutics Stock Forecast

BUY SELL NASDAQ:CTMX
$1.94 (5.43%)

Volume: 1.06M

Closed: Jul 05, 2022

Score Hollow Logo 3.577

CytomX Therapeutics Stock Price (Quote) NASDAQ:CTMX

$1.94 ( 5.43% ) Tuesday, 5th Jul 2022

Range Low Price High Price Comment
30 days $1.59 $2.00 Tuesday, 5th Jul 2022 CTMX stock ended at $1.94. This is 5.43% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 8.29% from a day low at $1.81 to a day high of $1.96.
90 days $1.51 $2.87
52 weeks $1.51 $7.53

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2022-07-05 $1.84 $1.96 $1.81 $1.94 1 060 330
2022-07-01 $1.89 $1.91 $1.84 $1.84 451 721
2022-06-30 $1.85 $1.90 $1.81 $1.83 554 355
2022-06-29 $1.85 $1.99 $1.80 $1.87 730 275
2022-06-28 $1.94 $1.94 $1.82 $1.86 875 853
2022-06-27 $1.90 $2.00 $1.86 $1.94 1 543 215
2022-06-24 $1.95 $2.00 $1.85 $1.90 10 443 867
2022-06-23 $1.80 $1.88 $1.78 $1.87 833 470
2022-06-22 $1.70 $1.84 $1.67 $1.80 1 243 869
2022-06-21 $1.64 $1.74 $1.61 $1.71 909 365
2022-06-17 $1.65 $1.73 $1.59 $1.60 1 360 886
2022-06-16 $1.70 $1.70 $1.59 $1.65 756 796
2022-06-15 $1.70 $1.76 $1.64 $1.72 829 120
2022-06-14 $1.77 $1.77 $1.66 $1.69 361 104
2022-06-13 $1.79 $1.79 $1.70 $1.75 580 936
2022-06-10 $1.88 $1.89 $1.79 $1.86 734 427
2022-06-09 $1.88 $1.96 $1.84 $1.95 710 502
2022-06-08 $1.90 $2.00 $1.89 $1.91 782 453
2022-06-07 $1.72 $1.94 $1.71 $1.89 1 105 661
2022-06-06 $1.78 $1.86 $1.73 $1.74 1 217 029
2022-06-03 $1.59 $1.81 $1.59 $1.78 806 162
2022-06-02 $1.57 $1.62 $1.52 $1.58 435 256
2022-06-01 $1.65 $1.70 $1.52 $1.55 803 213
2022-05-31 $1.62 $1.67 $1.59 $1.61 512 603
2022-05-27 $1.61 $1.65 $1.52 $1.62 941 366
2022-05-26 $1.54 $1.58 $1.51 $1.57 530 635
2022-05-25 $1.60 $1.63 $1.53 $1.53 796 009
2022-05-24 $1.56 $1.63 $1.52 $1.60 774 668
2022-05-23 $1.63 $1.64 $1.52 $1.58 732 506
2022-05-20 $1.70 $1.74 $1.56 $1.62 648 392
2022-05-19 $1.70 $1.76 $1.65 $1.69 870 118
2022-05-18 $1.82 $1.83 $1.68 $1.69 921 437
2022-05-17 $1.74 $1.87 $1.73 $1.86 1 282 109
2022-05-16 $1.75 $1.82 $1.71 $1.73 662 300
2022-05-13 $1.80 $1.81 $1.70 $1.76 1 115 783
2022-05-12 $1.62 $1.78 $1.62 $1.74 1 020 370
2022-05-11 $1.77 $1.82 $1.65 $1.66 1 187 625
2022-05-10 $1.57 $1.83 $1.55 $1.78 2 634 583
2022-05-09 $1.62 $1.65 $1.51 $1.53 1 055 268
2022-05-06 $1.69 $1.72 $1.53 $1.62 901 909
2022-05-05 $1.67 $1.70 $1.56 $1.61 1 393 972
2022-05-04 $1.72 $1.73 $1.59 $1.71 1 290 519
2022-05-03 $1.84 $1.86 $1.72 $1.72 1 237 394
2022-05-02 $1.71 $1.83 $1.71 $1.82 2 388 281
2022-04-29 $1.76 $1.82 $1.71 $1.71 1 057 601
2022-04-28 $1.82 $1.86 $1.71 $1.79 3 385 021
2022-04-27 $1.85 $1.91 $1.81 $1.81 1 556 607
2022-04-26 $1.96 $2.00 $1.84 $1.85 1 001 930
2022-04-25 $1.97 $2.01 $1.93 $1.96 1 200 746
2022-04-22 $2.02 $2.09 $1.95 $1.99 920 600

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 346 stocks, only a few dozen will trigger such a signal!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and Th... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT